Companies in #Fibrosis

Insilico Medicine is an end-to-end generative artificial intelligence-driven drug discovery company connecting biology, chemistry, and clinical trials analysis.

PureTech Health is a clinical-stage biotherapeutics company developing innovative medicines for serious diseases. It founded and spun out multiple companies including Karuna, Gelesis, and Celea, with a current focus on lymphatic and CNS-targeted therapeutics.

Redx Pharma is a clinical-stage biopharmaceutical company developing precision medicines targeting oncology and fibrotic diseases, with a pipeline of small molecule inhibitors of oncogenic and fibrotic pathways.

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead product, apitegromab, is being developed for spinal muscular atrophy (SMA).

Clinical-stage biopharmaceutical company developing peripheral CB1 receptor therapies for obesity and metabolic conditions. Recently combined with Redx Pharma into Fibrx Therapeutics to advance a fibrosis-focused pipeline.